Publication:
Quality of life in patients with breakthrough cancer pain in radiation oncology departments in Spain: the CAVIDIOR study.

dc.contributor.authorHernanz de Lucas, Raúl
dc.contributor.authorNuñez Fernández, Míriam
dc.contributor.authorGómez-Caamaño, Antonio
dc.contributor.authorMorera López, Rosa
dc.contributor.authorFortes de la Torre, Inmaculada
dc.contributor.authorde la Torre Tomás, Alejandro
dc.contributor.authorMuñoz-Garzón, Víctor
dc.contributor.authorLópez Bermudo, Cristina
dc.contributor.authorMañas Rueda, Ana
dc.date.accessioned2023-02-09T10:38:07Z
dc.date.available2023-02-09T10:38:07Z
dc.date.issued2020-12-08
dc.description.abstractAim: The CAVIDIOR study evaluated quality of life (QoL) in patients with breakthrough cancer pain receiving palliative radiation therapy in radiation oncology departments (RODs) in Spain. Patients & methods: Prospective observational study at 11 Spanish RODs (July 2016-November 2017). QoL was assessed using Short Form Health Survey 12. Secondary end points were sleep quality, caregiver burden and patient/perception of improvement. Results: QoL improved according to the Short Form Health Survey 12 mental component. Sleep quality and caregivers' burden improved significantly. Conclusion: Breakthrough cancer pain is highly prevalent and can be substantially reduced with appropriate diagnosis and management in RODs. Along with the QoL questionnaire, sleep quality and caregiver burden provide a more comprehensive assessment of overall health status in patients receiving radiation therapy in RODs. Clinical trial registration: NCT02836379 (ClinicalTrials.gov).
dc.identifier.doi10.2217/fon-2020-1063
dc.identifier.essn1744-8301
dc.identifier.pmid33289432
dc.identifier.unpaywallURLhttps://doi.org/10.2217/fon-2020-1063
dc.identifier.urihttp://hdl.handle.net/10668/16753
dc.issue.number8
dc.journal.titleFuture oncology (London, England)
dc.journal.titleabbreviationFuture Oncol
dc.language.isoen
dc.organizationHospital Universitario Regional de Málaga
dc.page.number943-954
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.pubmedtypeObservational Study
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectbreakthrough cancer pain
dc.subjectpalliative care
dc.subjectquality of life
dc.subjectradiation oncology
dc.subjecttransmucosal fentanyl
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshBreakthrough Pain
dc.subject.meshCancer Pain
dc.subject.meshCaregivers
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshNeoplasms
dc.subject.meshPain Measurement
dc.subject.meshPalliative Care
dc.subject.meshProspective Studies
dc.subject.meshQuality of Life
dc.subject.meshRadiation Oncology
dc.subject.meshSpain
dc.titleQuality of life in patients with breakthrough cancer pain in radiation oncology departments in Spain: the CAVIDIOR study.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number17
dspace.entity.typePublication

Files